Navigation Links
Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
Date:3/10/2008

PINE BROOK, N.J., March 10 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a privately held biopharmaceutical company developing antibody-based therapies for the treatment of life-threatening infectious diseases, today announced the appointment of Robert Gundel, Ph.D., M.B.A., as Vice President of Research.

Elizabeth G. Posillico, Ph.D., President and Chief Executive Officer, commented on the appointment, "On behalf of Elusys' Board of Directors and management, I am very pleased to welcome Bob to our executive management team. As Vice President of Research, he will play a key role in helping to further develop and advance our corporate and scientific strategies. With more than twenty-five years of experience in developing monoclonal antibody-based products from both the biotech and pharmaceutical sectors, Dr. Gundel will lead our existing R&D team to further the development of our antibody based products for the treatment of infectious disease. He will also use his expertise to evaluate new product opportunities and will play a key leadership role in managing our existing and future R&D collaborations."

Prior to joining Elusys, Dr. Gundel held executive management positions at a number of leading biopharmaceutical companies including, Bayer, Chiron, XOMA and ARIUS. Most recently, Dr. Gundel served as Chief Scientific Officer at ARIUS Research, Inc., a biotechnology company focused on the discovery and development of therapeutic antibodies for the treatment of cancer and other diseases. At ARIUS, he managed the drug discovery and development programs and worked to broaden the company's targeted therapeutic areas by identifying and developing new programs outside of oncology. He also identified new technologies to keep the company ahead of the curve for therapeutic drug discovery, development and manufacturing.

Previously, Dr. Gundel was Vice President, Preclinical Research and Scientific Corporate Development at XOMA (US), LLC, a biote
'/>"/>

SOURCE Elusys Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cell Therapeutics, Inc. (CTI) to Present at 7th Annual WBBA Invest Northwest Conference
2. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
3. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End Financial Results on March 13
4. ExonHit Therapeutics - 2007 Financial Results
5. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
6. Cell Therapeutics, Inc. to Hold Conference Call to Update on Recent Transactions and Upcoming Milestones
7. M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
8. CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results
9. TorreyPines Therapeutics to Present at Susquehanna Financial Groups Second Annual SIGnificant Options in Healthcare Conference
10. Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics
11. The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... D.C (PRWEB) September 22, 2014 FierceBiotech ... top privately held biotechnology companies of 2014. FierceBiotech ... companies before selecting this year’s winners. Those selected ... biotechnology companies in the industry. , "It's ... new group of Fierce 15 companies," said Carroll. "This ...
(Date:9/22/2014)... , Sept. 22, 2014  Spherix Incorporated (SPEX) -- an ... of intellectual property, today announced that the United States Patent ... Company in the month of September that is part of ... issued patent is: USRE45,121 , Application number: US ... Filing date: Dec 27, 2012 The listed ...
(Date:9/20/2014)... 2014 HealthTronics, Inc. , ... radiology products and services, has signed a distribution ... Clinicon Corporation for its high precision laser ... minimally invasive, mobile, surgical technology—offering more choices for ... agreement, HealthTronics will make available Clinicon’s FDA-cleared SureLase™ ...
(Date:9/19/2014)... rather than electricity, to move data would consume ... a growing concern as chips, transistor counts rise. ... circuits light emitters, modulators, and detectors ... light source for optical chips is molybdenum disulfide ... as a single, atom-thick layer. Other experimental on-chip ...
Breaking Biology Technology:FierceBiotech Announces Annual “Fierce 15” Winners of 2014 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 3HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 2HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 3Toward optical chips 2Toward optical chips 3
... detect broken bones, tumors and dental cavities, analyze atoms in ... knew they could cause crystals to form? A team ... the formation of a new type of crystal: charged cylindrical ... which is unknown in crystals. Similar phenomena may occur naturally ...
... , , , , ... 25 /PRNewswire-Asia/ -- China,Yongxin Pharmaceuticals, Inc. (OTC Bulletin Board: ... distributor and,retailer of Chinese traditional medicines, pharmaceutical products, natural,health products, ... The Company today announced that it plans to open twenty ...
... , ... ,Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in ... important milestone in the official,marketing authorisation process for ... lipase deficiency (LPLD). The submission,of the Glybera(R) Marketing ...
Cached Biology Technology:Surprising discovery: X-rays drive formation of new crystals 2China Yongxin Pharmaceuticals Plans to Open Eighteen New Stores in 2010 to Further Expand Customer Base and Increase Market Share 2China Yongxin Pharmaceuticals Plans to Open Eighteen New Stores in 2010 to Further Expand Customer Base and Increase Market Share 3China Yongxin Pharmaceuticals Plans to Open Eighteen New Stores in 2010 to Further Expand Customer Base and Increase Market Share 4EMA Starts Formal Review of Glybera(R) Dossier 2EMA Starts Formal Review of Glybera(R) Dossier 3
(Date:9/18/2014)... N.Y. A sleep-promoting circuit located deep in the ... sleep. Discovered by researchers at Harvard School of Medicine ... Biomedical Sciences, this is only the second "sleep node" ... be both necessary and sufficient to produce deep sleep. ... , the study demonstrates that fully half of all ...
(Date:9/18/2014)... robotic system that can operate inside the bore of ... of a biomedical research partnership program at Brigham and ... if the robot, in conjunction with real-time MRI images, ... costly, and less discomforting for the patient. The novel ... therapies with greater precision. , Developed by a team ...
(Date:9/18/2014)... many times it,s demonstrated, it,s still hard to ... But by using a signaling system called "quorum ... to suit their population. In short, some bacteria ... act accordingly. , Once the population of quorum-sensing ... innocuous to pathogenic, or from unhelpful to helpful. ...
Breaking Biology News(10 mins):No sedative necessary: Scientists discover new 'sleep node' in the brain 2Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 2Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 3Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 4Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 5Researchers study vital 'on/off switches' that control when bacteria turn deadly 2Researchers study vital 'on/off switches' that control when bacteria turn deadly 3
... of the world,s biggest killers for as long as records ... the rise, there is a renewed push to find different ... have stepped up to the plate to answer the call. ... department of chemical and biomolecular engineering, recently were awarded a ...
... Now computers are at it again, but this ... itself. An interdisciplinary team of scientists at Vanderbilt ... taken a major step toward this goal by demonstrating ... a biological system and derive the basic mathematical equations ...
... has been associated with cognitive decline, characterized by a ... thought-processing speed. But in a study of 300 post-menopausal ... in Argentina, obese participants in the study performed better ... leading researchers to speculate about the role of sex ...
Cached Biology News:UH engineers finding new ways to fight malaria with DOD grant 2Robot biologist solves complex problem from scratch 2Robot biologist solves complex problem from scratch 3Association between menopause, obesity and cognitive impairment 2
Mitochondria/Cytosol Fractionation Kit Research Focus: other Storage Temperature: 4C Shipping Temperature: 4C...
... increasing age, the autofluorescent pigment lipofuscin ... cell types, including neurons. The presence ... use of fluorescence microscopy in the ... broad excitation and emission spectra, which ...
... the family of calcium binding proteins such as ... of an alpha and beta chain whereas S100B ... protein is also expressed in the antigen presenting ... and interdigitating reticulum cells in the paracortex of ...
LEAF™ Purified anti-human/mouse/rat ICOS...
Biology Products: